Your browser doesn't support javascript.
loading
Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease.
Ivanova, Margarita M; Dao, Julia; Kasaci, Neil; Friedman, Andrew; Noll, Lauren; Goker-Alpan, Ozlem.
Affiliation
  • Ivanova MM; Translational Research, Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, VA, United States.
  • Dao J; Translational Research, Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, VA, United States.
  • Kasaci N; Translational Research, Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, VA, United States.
  • Friedman A; Translational Research, Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, VA, United States.
  • Noll L; Translational Research, Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, VA, United States.
  • Goker-Alpan O; Translational Research, Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, VA, United States.
Front Endocrinol (Lausanne) ; 13: 1029130, 2022.
Article in En | MEDLINE | ID: mdl-36506070
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteoporosis / Gaucher Disease Type of study: Etiology_studies Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteoporosis / Gaucher Disease Type of study: Etiology_studies Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2022 Type: Article Affiliation country: United States